GMP Manufacturing Services
Utilizing custom design and development
to achieve regulatory approval
ABL has a long and successful history as a CDMO providing contract development and GMP biomanufacturing services to the biotech and biopharmaceutical industry. Our primary focus is viral vector manufacturing and we operate GMP facilities in the U.S. and Europe to meet your global regulatory and redundancy requirements. ABL offers a comprehensive portfolio of effective design, development, production and testing services for a broad range of virus products.
The success of your novel product starts with ABL
ABL’s 30+ years of viral-vector development and GMP production accelerates your novel gene therapies, vaccines, oncolytics and immunotherapies.
YEARS OF EXPERIENCE
Viral Vector Manufacturing Experts
Our product types
Experience producing numerous viral vectors for
Gene therapies | Vaccines | Oncolytics | Immunotherapies
When developing life changing innovations,
the right strategic partner makes the difference
Comprehensive GMP Manufacturing Support
ABL’s U.S. location adheres to Good Manufacturing Practice (GMP) standards and is ISO 9001 accredited. ABL Europe’s facilities are regularly inspected by the French regulatory authorities (ANSM) and is a GMP licensed site for the manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products in accordance with EMA regulations.
Global GMP Manufacturing Facilities
Our U.S. and European compliant facilities are available for GMP production of clinical, pre-clinical trials, and commercial material with iCELLis 500+ platform ready for use. See our New Capabilities.
Learn about our biomanufacturing services
In addition to the services listed above, ask about our protein manufacturing and GMP antibody production services.